Literature DB >> 12832465

Mek2 is dispensable for mouse growth and development.

Louis-François Bélanger1, Sophie Roy, Michel Tremblay, Barbara Brott, Ann-Muriel Steff, Walid Mourad, Patrice Hugo, Raymond Erikson, Jean Charron.   

Abstract

MEK is a dual-specificity kinase that activates the extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase upon agonist binding to receptors. The ERK/MAP kinase cascade is involved in cell fate determination in many organisms. In mammals, this pathway is proposed to regulate cell growth and differentiation. Genetic studies have shown that although a single Mek gene is present in Caenorhabditis elegans, Drosophila melanogaster, and Xenopus laevis, two Mek homologs, Mek1 and Mek2, are present in the mammalian cascade. The inactivation of the Mek1 gene leads to embryonic lethality and has revealed the unique role played by Mek1 during embryogenesis. To investigate the biological function of the second homolog, we have generated mice deficient in Mek2 function. Mek2 mutant mice are viable and fertile, and they do not present flagrant morphological alteration. Although several components of the ERK/MAP kinase cascade have been implicated in thymocyte development, no such involvement was observed for MEK2, which appears to be nonessential for thymocyte differentiation and T-cell-receptor-induced proliferation and apoptosis. Altogether, our findings demonstrate that MEK2 is not necessary for the normal development of the embryo and T-cell lineages, suggesting that the loss of MEK2 can be compensated for by MEK1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832465      PMCID: PMC162209          DOI: 10.1128/MCB.23.14.4778-4787.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte.

Authors:  T Crompton; K C Gilmour; M J Owen
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

2.  WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras.

Authors:  E Ioffe; Y Liu; M Bhaumik; F Poirier; S M Factor; P Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

3.  Generation of normal lymphocytes derived from N-myc-deficient embryonic stem cells.

Authors:  B A Malynn; J Demengeot; V Stewart; J Charron; F W Alt
Journal:  Int Immunol       Date:  1995-10       Impact factor: 4.823

4.  Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells.

Authors:  X Wu; S J Noh; G Zhou; J E Dixon; K L Guan
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

5.  MEK activity regulates negative selection of immature CD4+CD8+ thymocytes.

Authors:  U Bommhardt; Y Scheuring; C Bickel; R Zamoyska; T Hünig
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

6.  Reduced requirement of mitogen-activated protein kinase (MAPK) activity for entry into the S phase of the cell cycle in Swiss 3T3 fibroblasts stimulated by bombesin and insulin.

Authors:  T Seufferlein; D J Withers; E Rozengurt
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

7.  Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system.

Authors:  C Papin; A Denouel; G Calothy; A Eychène
Journal:  Oncogene       Date:  1996-05-16       Impact factor: 9.867

8.  Lactosylceramide stimulates Ras-GTP loading, kinases (MEK, Raf), p44 mitogen-activated protein kinase, and c-fos expression in human aortic smooth muscle cells.

Authors:  A K Bhunia; H Han; A Snowden; S Chatterjee
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

9.  Preferential involvement of MEK1 in the tumor necrosis factor-alpha-induced activation of p42mapk/erk2 in mouse macrophages.

Authors:  B W Winston; L K Remigio; D W Riches
Journal:  J Biol Chem       Date:  1995-11-17       Impact factor: 5.157

10.  Positive and negative selection invoke distinct signaling pathways.

Authors:  J Alberola-Ila; K A Hogquist; K A Swan; M J Bevan; R M Perlmutter
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  65 in total

1.  c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma.

Authors:  Rafael B Blasco; Sarah Francoz; David Santamaría; Marta Cañamero; Pierre Dubus; Jean Charron; Manuela Baccarini; Mariano Barbacid
Journal:  Cancer Cell       Date:  2011-04-21       Impact factor: 31.743

2.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

Review 3.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

4.  Rapamycin induces mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) expression through activation of protein kinase B and mitogen-activated protein kinase kinase pathways.

Authors:  Ruchi Rastogi; Zhongliang Jiang; Nisar Ahmad; Rita Rosati; Yusen Liu; Laurent Beuret; Robert Monks; Jean Charron; Morris J Birnbaum; Lobelia Samavati
Journal:  J Biol Chem       Date:  2013-10-14       Impact factor: 5.157

5.  Specific functions for ERK/MAPK signaling during PNS development.

Authors:  Jason M Newbern; Xiaoyan Li; Sarah E Shoemaker; Jiang Zhou; Jian Zhong; Yaohong Wu; Daniel Bonder; Steven Hollenback; Giovanni Coppola; Daniel H Geschwind; Gary E Landreth; William D Snider
Journal:  Neuron       Date:  2011-01-13       Impact factor: 17.173

6.  Theoretical and experimental analysis links isoform-specific ERK signalling to cell fate decisions.

Authors:  Marcel Schilling; Thomas Maiwald; Stefan Hengl; Dominic Winter; Clemens Kreutz; Walter Kolch; Wolf D Lehmann; Jens Timmer; Ursula Klingmüller
Journal:  Mol Syst Biol       Date:  2009-12-22       Impact factor: 11.429

7.  MEK2 Negatively Regulates Lipopolysaccharide-Mediated IL-1β Production through HIF-1α Expression.

Authors:  Harvinder Talwar; Mohamad Bouhamdan; Christian Bauerfeld; Jaya Talreja; Rifdat Aoidi; Nicolas Houde; Jean Charron; Lobelia Samavati
Journal:  J Immunol       Date:  2019-02-01       Impact factor: 5.422

8.  Post-transcriptional regulation of MEK-1 by polyamines through the RNA-binding protein HuR modulating intestinal epithelial apoptosis.

Authors:  Peng-Yuan Wang; Jaladanki N Rao; Tongtong Zou; Lan Liu; Lan Xiao; Ting-Xi Yu; Douglas J Turner; Myriam Gorospe; Jian-Ying Wang
Journal:  Biochem J       Date:  2010-02-24       Impact factor: 3.857

9.  A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal.

Authors:  Federica Catalanotti; Gloria Reyes; Veronika Jesenberger; Gergana Galabova-Kovacs; Ricardo de Matos Simoes; Oliviero Carugo; Manuela Baccarini
Journal:  Nat Struct Mol Biol       Date:  2009-02-15       Impact factor: 15.369

Review 10.  How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?

Authors:  Yohannes Mebratu; Yohannes Tesfaigzi
Journal:  Cell Cycle       Date:  2009-04-11       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.